Birdwatch Note
2023-10-03 19:17:04 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
イベルメクチンは寄生虫の駆虫薬として承認されており、新型コロナ（COVID-19）の後遺症特効薬や症状改善などの効果は認められておりません。 これは日本でも発見者の母学である北里大学と発売元である興和が治験をして有効性が無かったことを確認しております。 北里大学 https://www.kitasato-u.ac.jp/khp/topics/2022/20220930.html 興和株式会社 https://www.kowa.co.jp/news/2022/press20220926.html インドでも公的にイベルメクチンを予防と治療ガイドラインに含めないようにアップデートされています。 イベルメクチンが新型コロナの特効薬であるという言説は、ワクチンの有効性と毒性に関するデータを読み解けない人を対象にしたデマですのでご注意ください。
Written by C6357C0DDBA4954E41207104BE7A180DC6109DA47E4B3BFA80E75210B39C9406
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1709121927623885037
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1709286463928758623
- noteId - 1709286463928758623
- participantId -
- noteAuthorParticipantId - C6357C0DDBA4954E41207104BE7A180DC6109DA47E4B3BFA80E75210B39C9406 Participant Details
- createdAtMillis - 1696360624667
- tweetId - 1709121927623885037
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 1
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- イベルメクチンは寄生虫の駆虫薬として承認されており、新型コロナ（COVID-19）の後遺症特効薬や症状改善などの効果は認められておりません。 これは日本でも発見者の母学である北里大学と発売元である興和が治験をして有効性が無かったことを確認しております。 北里大学 https://www.kitasato-u.ac.jp/khp/topics/2022/20220930.html 興和株式会社 https://www.kowa.co.jp/news/2022/press20220926.html インドでも公的にイベルメクチンを予防と治療ガイドラインに含めないようにアップデートされています。 イベルメクチンが新型コロナの特効薬であるという言説は、ワクチンの有効性と毒性に関するデータを読み解けない人を対象にしたデマですのでご注意ください。
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-10-03 19:17:04 UTC (1696360624667) |
2023-10-04 01:29:30 UTC (1696382970777) |
CURRENTLY_RATED_HELPFUL | 2023-10-04 02:49:07 UTC (1696387747507) |
CURRENTLY_RATED_HELPFUL | 2023-10-04 01:29:30 UTC (1696382970777) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2023-10-03 19:31:22 -0500 | Rating Details | |
| 2023-10-03 19:28:06 -0500 | Rating Details | |
| 2023-10-03 19:24:07 -0500 | Rating Details | |
| 2023-10-03 19:20:38 -0500 | Rating Details | |
| 2023-10-03 19:16:54 -0500 | Rating Details | |
| 2023-10-03 19:15:33 -0500 | Rating Details | |
| 2023-10-03 19:05:53 -0500 | Rating Details | |
| 2023-10-03 19:03:13 -0500 | Rating Details | |
| 2023-10-03 18:56:26 -0500 | Rating Details | |
| 2023-10-03 18:51:17 -0500 | Rating Details | |
| 2023-10-03 18:39:07 -0500 | Rating Details | |
| 2023-10-03 18:36:13 -0500 | Rating Details | |
| 2023-10-03 18:35:18 -0500 | Rating Details | |
| 2023-10-03 18:31:49 -0500 | Rating Details | |
| 2023-10-03 18:31:42 -0500 | Rating Details | |
| 2023-10-03 18:29:41 -0500 | Rating Details | |
| 2023-10-03 18:27:14 -0500 | Rating Details | |
| 2023-10-03 18:06:59 -0500 | Rating Details | |
| 2023-10-03 17:38:47 -0500 | Rating Details | |
| 2023-10-03 17:35:10 -0500 | Rating Details | |
| 2023-10-03 17:25:20 -0500 | Rating Details | |
| 2023-10-03 17:23:07 -0500 | Rating Details | |
| 2023-10-03 17:19:18 -0500 | Rating Details | |
| 2023-10-03 17:18:46 -0500 | Rating Details | |
| 2023-10-03 17:09:58 -0500 | Rating Details | |
| 2023-10-03 17:05:55 -0500 | Rating Details | |
| 2023-10-03 17:01:29 -0500 | Rating Details | |
| 2023-10-03 16:51:52 -0500 | Rating Details | |
| 2023-10-03 16:51:52 -0500 | Rating Details | |
| 2023-10-03 16:50:31 -0500 | Rating Details | |
| 2023-10-03 16:50:29 -0500 | Rating Details | |
| 2023-10-03 16:40:28 -0500 | Rating Details | |
| 2023-10-03 16:37:21 -0500 | Rating Details | |
| 2023-10-03 16:36:54 -0500 | Rating Details | |
| 2023-10-03 16:22:15 -0500 | Rating Details | |
| 2023-10-03 16:21:16 -0500 | Rating Details | |
| 2023-10-03 16:13:59 -0500 | Rating Details | |
| 2023-10-03 16:03:59 -0500 | Rating Details | |
| 2023-10-03 16:03:47 -0500 | Rating Details | |
| 2023-10-03 15:45:02 -0500 | Rating Details | |
| 2023-10-03 15:25:57 -0500 | Rating Details | |
| 2023-10-03 15:09:52 -0500 | Rating Details | |
| 2023-10-03 14:40:55 -0500 | Rating Details | |
| 2023-10-03 14:33:01 -0500 | Rating Details | |
| 2023-10-04 19:04:29 -0500 | Rating Details | |
| 2023-10-04 18:33:23 -0500 | Rating Details | |
| 2023-10-04 18:26:48 -0500 | Rating Details | |
| 2023-10-04 17:43:53 -0500 | Rating Details | |
| 2023-10-04 17:40:37 -0500 | Rating Details | |
| 2023-10-04 17:11:12 -0500 | Rating Details | |
| 2023-10-04 17:05:12 -0500 | Rating Details | |
| 2023-10-04 16:31:48 -0500 | Rating Details | |
| 2023-10-04 16:30:10 -0500 | Rating Details | |
| 2023-10-04 16:22:55 -0500 | Rating Details | |
| 2023-10-04 16:15:53 -0500 | Rating Details | |
| 2023-10-04 15:59:09 -0500 | Rating Details | |
| 2023-10-04 15:58:51 -0500 | Rating Details | |
| 2023-10-04 15:56:41 -0500 | Rating Details | |
| 2023-10-04 12:21:43 -0500 | Rating Details | |
| 2023-10-04 12:01:38 -0500 | Rating Details | |
| 2023-10-04 11:59:50 -0500 | Rating Details | |
| 2023-10-04 11:48:34 -0500 | Rating Details | |
| 2023-10-04 10:57:35 -0500 | Rating Details | |
| 2023-10-04 09:34:30 -0500 | Rating Details | |
| 2023-10-04 09:01:09 -0500 | Rating Details | |
| 2023-10-04 08:34:25 -0500 | Rating Details | |
| 2023-10-04 08:27:10 -0500 | Rating Details | |
| 2023-10-04 08:15:53 -0500 | Rating Details | |
| 2023-10-04 07:45:54 -0500 | Rating Details | |
| 2023-10-04 07:38:51 -0500 | Rating Details | |
| 2023-10-04 07:36:21 -0500 | Rating Details | |
| 2023-10-04 07:33:25 -0500 | Rating Details | |
| 2023-10-04 07:14:22 -0500 | Rating Details | |
| 2023-10-04 06:46:25 -0500 | Rating Details | |
| 2023-10-04 06:44:12 -0500 | Rating Details | |
| 2023-10-04 06:40:25 -0500 | Rating Details | |
| 2023-10-04 06:18:01 -0500 | Rating Details | |
| 2023-10-04 06:06:43 -0500 | Rating Details | |
| 2023-10-04 05:49:11 -0500 | Rating Details | |
| 2023-10-04 05:47:13 -0500 | Rating Details | |
| 2023-10-04 05:33:16 -0500 | Rating Details | |
| 2023-10-04 05:30:31 -0500 | Rating Details | |
| 2023-10-04 05:27:14 -0500 | Rating Details | |
| 2023-10-04 05:22:09 -0500 | Rating Details | |
| 2023-10-04 05:05:42 -0500 | Rating Details | |
| 2023-10-04 04:45:47 -0500 | Rating Details | |
| 2023-10-04 04:36:39 -0500 | Rating Details | |
| 2023-10-04 04:31:17 -0500 | Rating Details | |
| 2023-10-04 04:29:13 -0500 | Rating Details | |
| 2023-10-04 04:16:14 -0500 | Rating Details | |
| 2023-10-04 04:11:45 -0500 | Rating Details | |
| 2023-10-04 04:08:46 -0500 | Rating Details | |
| 2023-10-04 04:07:03 -0500 | Rating Details | |
| 2023-10-04 03:42:48 -0500 | Rating Details | |
| 2023-10-04 03:37:31 -0500 | Rating Details | |
| 2023-10-04 03:32:46 -0500 | Rating Details | |
| 2023-10-04 03:29:57 -0500 | Rating Details | |
| 2023-10-04 03:27:06 -0500 | Rating Details | |
| 2023-10-04 03:20:05 -0500 | Rating Details | |
| 2023-10-04 03:08:38 -0500 | Rating Details | |
| 2023-10-04 02:59:19 -0500 | Rating Details | |
| 2023-10-04 02:58:34 -0500 | Rating Details | |
| 2023-10-04 02:57:46 -0500 | Rating Details | |
| 2023-10-04 02:55:57 -0500 | Rating Details | |
| 2023-10-04 02:55:51 -0500 | Rating Details | |
| 2023-10-04 02:49:08 -0500 | Rating Details | |
| 2023-10-04 02:48:31 -0500 | Rating Details | |
| 2023-10-04 02:48:20 -0500 | Rating Details | |
| 2023-10-04 02:43:26 -0500 | Rating Details | |
| 2023-10-04 02:42:13 -0500 | Rating Details | |
| 2023-10-04 02:36:22 -0500 | Rating Details | |
| 2023-10-04 02:32:58 -0500 | Rating Details | |
| 2023-10-04 02:21:33 -0500 | Rating Details | |
| 2023-10-04 01:56:29 -0500 | Rating Details | |
| 2023-10-04 01:49:51 -0500 | Rating Details | |
| 2023-10-04 01:48:13 -0500 | Rating Details | |
| 2023-10-04 01:46:31 -0500 | Rating Details | |
| 2023-10-04 01:45:53 -0500 | Rating Details | |
| 2023-10-04 01:43:24 -0500 | Rating Details | |
| 2023-10-04 01:33:30 -0500 | Rating Details | |
| 2023-10-04 01:31:12 -0500 | Rating Details | |
| 2023-10-04 01:31:02 -0500 | Rating Details | |
| 2023-10-04 01:29:43 -0500 | Rating Details | |
| 2023-10-04 01:28:46 -0500 | Rating Details | |
| 2023-10-04 01:28:46 -0500 | Rating Details | |
| 2023-10-04 01:08:05 -0500 | Rating Details | |
| 2023-10-04 00:32:27 -0500 | Rating Details | |
| 2023-10-04 00:16:17 -0500 | Rating Details | |
| 2023-10-03 23:46:07 -0500 | Rating Details | |
| 2023-10-03 23:45:55 -0500 | Rating Details | |
| 2023-10-03 23:28:14 -0500 | Rating Details | |
| 2023-10-03 23:09:03 -0500 | Rating Details | |
| 2023-10-03 22:43:37 -0500 | Rating Details | |
| 2023-10-03 21:08:35 -0500 | Rating Details | |
| 2023-10-03 21:02:49 -0500 | Rating Details | |
| 2023-10-03 20:50:00 -0500 | Rating Details | |
| 2023-10-03 20:48:55 -0500 | Rating Details | |
| 2023-10-03 20:09:31 -0500 | Rating Details | |
| 2023-10-03 20:06:54 -0500 | Rating Details | |
| 2023-10-03 20:03:49 -0500 | Rating Details | |
| 2023-10-03 20:03:43 -0500 | Rating Details | |
| 2023-10-03 20:02:56 -0500 | Rating Details | |
| 2023-10-03 20:02:15 -0500 | Rating Details | |
| 2023-10-03 19:46:42 -0500 | Rating Details | |
| 2023-10-03 19:42:52 -0500 | Rating Details | |
| 2023-10-03 19:32:09 -0500 | Rating Details | |
| 2023-10-05 13:59:46 -0500 | Rating Details | |
| 2023-10-05 08:31:07 -0500 | Rating Details | |
| 2023-10-05 05:15:08 -0500 | Rating Details | |
| 2023-10-05 04:41:42 -0500 | Rating Details | |
| 2023-10-05 03:52:22 -0500 | Rating Details | |
| 2023-10-05 02:42:05 -0500 | Rating Details | |
| 2023-10-05 02:06:47 -0500 | Rating Details | |
| 2023-10-05 02:05:26 -0500 | Rating Details | |
| 2023-10-05 00:53:45 -0500 | Rating Details | |
| 2023-10-05 00:36:31 -0500 | Rating Details | |
| 2023-10-05 00:03:49 -0500 | Rating Details | |
| 2023-10-04 23:25:17 -0500 | Rating Details | |
| 2023-10-04 22:25:21 -0500 | Rating Details | |
| 2023-10-04 21:39:52 -0500 | Rating Details | |
| 2023-10-04 21:22:01 -0500 | Rating Details | |
| 2023-10-04 21:10:32 -0500 | Rating Details | |
| 2023-10-04 20:55:09 -0500 | Rating Details | |
| 2023-10-04 19:47:56 -0500 | Rating Details | |
| 2023-10-04 19:34:59 -0500 | Rating Details | |
| 2023-10-06 05:40:48 -0500 | Rating Details | |
| 2023-10-05 23:27:44 -0500 | Rating Details | |
| 2023-10-08 04:52:00 -0500 | Rating Details | |
| 2023-10-05 09:06:03 -0500 | Rating Details | |
| 2023-10-04 21:38:41 -0500 | Rating Details | |
| 2023-10-04 19:02:03 -0500 | Rating Details | |
| 2023-10-04 17:35:09 -0500 | Rating Details | |
| 2023-10-04 12:20:47 -0500 | Rating Details | |
| 2023-10-04 12:02:16 -0500 | Rating Details | |
| 2023-10-04 11:28:49 -0500 | Rating Details | |
| 2023-10-04 08:21:27 -0500 | Rating Details | |
| 2023-10-04 06:46:12 -0500 | Rating Details | |
| 2023-10-04 06:23:14 -0500 | Rating Details | |
| 2023-10-04 04:41:08 -0500 | Rating Details | |
| 2023-10-04 04:37:38 -0500 | Rating Details | |
| 2023-10-04 03:29:05 -0500 | Rating Details | |
| 2023-10-04 03:19:38 -0500 | Rating Details | |
| 2023-10-04 03:03:03 -0500 | Rating Details | |
| 2023-10-04 02:53:42 -0500 | Rating Details | |
| 2023-10-04 02:33:06 -0500 | Rating Details | |
| 2023-10-04 02:32:23 -0500 | Rating Details | |
| 2023-10-09 05:17:13 -0500 | Rating Details | |
| 2024-01-14 19:04:57 -0600 | Rating Details | |
| 2024-01-14 18:38:57 -0600 | Rating Details | |
| 2024-06-10 06:31:26 -0500 | Rating Details | |
| 2024-06-10 04:59:18 -0500 | Rating Details |